Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Israel / NCT06181396
Recruiting Not applicable

Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes

NCT06181396 · tracked via the Priya Life Science Israel tracker
Sponsor
Rambam Health Care Campus
Phase
Not applicable
Started
2023-10-01
Last updated
2023-12-26

Condition(s) studied

Delivery ComplicationCesarean Delivery Affecting Fetus

Investigational drug(s) / intervention(s)

Oxytocin →

Oxytocin: Native oxytocin analog

Study summary

Early oxytocin administration at the 2nd stage of labor is associated with a higher rate of vaginal delivery, shorter second stage duration, and fewer adverse maternal and neonatal outcomes.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: 1. Singleton pregnancy 2. Maternal age ≥ 18 years' old 3. Oxytocin administration initiated or renewed during second stage of labor Exclusion Criteria: 1. Maternal age \< 18 years' old 2. Multiple gestation pregnancy 3. Known fetal malformations 4. Uterine scar

Primary outcome measure(s)

  • Mode of delivery — Delivery
    Vaginal or instrumental or cesarean

Trial sites (1)

FacilityCityRegionStatus
Rambam medical health campus Haifa Israel Recruiting

More Rambam Health Care Campus trials in Israel

Administration Of Calcium Gluconate for The Reduction of Blood Loss During Vaginal Delivery Recruiting
Artificial Intelligence as a Decision Making Tool in Emergency Department Active, not recruiting
Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants. Recruiting
Low Dose Antenatal Corticosteroids for Late Preterm Delivery Recruiting
Delayed Surveillance Colonoscopy Following Piecemeal EMR Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06181396 on ClinicalTrials.gov ↗ ← All trials in Israel